The Value of Combining CYP2C19*2 Polymorphism with Classic Risk Factors in Prediction of Clinical Prognosis in Acute Coronary Syndrome Patients

By  

Cardiology, Vol. 119, Iss. 1, 2011-07 ,pp. : 15-20

Karger

Access to resources Recommend Favorite

Prevalence of CYP2C19 alleles, pharmacokinetic and pharmacodynamic variation of clopidogrel and prasugrel in Bangladeshi population

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 451-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital

By Ruañño Gualberto   Villagra David   Rahim Umme Salma   Windemuth Andreas   Kocherla Mohan   Bower Bruce   Szarek Bonnie L   Goethe John W  

Personalized Medicine, Vol. 5, Iss. 6, 2008-11 ,pp. : 579-587

Future Medicine

Access to resources Recommend Favorite

Distribution of CYP2C9 and VKORC1 Risk Alleles for Warfarin Sensitivity and Resistance in the Israeli Population

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-01 ,pp. : 190-193

Bentham Science Publishers

Access to resources Recommend Favorite

Variant VKORC1 and CYP2C9 Alleles in Patients with Diffuse Alveolar Hemorrhage Caused by Oral Anticoagulants

By Wijnen Petal A.   Linssen Catharina F.   Haenen Guido R.   Bekers Otto   Drent Marjolein  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 23-30

Adis International

Access to resources Recommend Favorite